57 results
424B5
XENE
Xenon Pharmaceuticals Inc
30 Nov 23
Prospectus supplement for primary offering
4:18pm
in restrictions on the product or on the manufacturing or laboratory facility, including product recall, suspension of manufacturing, importation
424B5
XENE
Xenon Pharmaceuticals Inc
29 Nov 23
Prospectus supplement for primary offering
5:05pm
recall, suspension of manufacturing, importation bans, product seizure or a voluntary withdrawal of the drug from the market. Any failure by our, or our
424B5
ymql3rl6re0s56m
23 Jun 22
Prospectus supplement for primary offering
4:09pm
424B5
goi 9wbyr
22 Jun 22
Prospectus supplement for primary offering
4:05pm
424B5
brs6qrbinlmbt 3utc12
1 Mar 22
Prospectus supplement for primary offering
5:12pm
424B5
yln6m8
6 Oct 21
Prospectus supplement for primary offering
5:05pm
424B5
9s251mcyl wkkyr
4 Oct 21
Prospectus supplement for primary offering
5:27pm
424B5
0go84mnsgvp uo0
9 Mar 21
Prospectus supplement for primary offering
5:26pm